Phase 1 Pharmacokinetic (PK) Study to Evaluate Once-weekly Corplex™ Donepezil Transdermal Delivery System Compared to Daily Oral Administration of Aricept® in Healthy Adult Subjects
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Donepezil (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Corium International
- 28 Jul 2017 Planned End Date changed from 1 Nov 2017 to 1 Jan 2018.
- 28 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 18 Jul 2017 According to a Corium International media release, results from this trial have been presented at the Alzheimer's Association International Conference 2017 (AAIC).